Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag at the bottom of the page updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer release. This reflects a minor update or bug fix rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label was introduced. The old Intervention / Treatment label and the prior revision note (v3.5.5) were removed.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer edition of the page was published.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision metadata on the page was updated from v3.5.3 to v3.5.4, signifying a new version of the page. There are no changes to the study content or user-facing data indicated by this update.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s footer/site release revision was updated from v3.5.2 to v3.5.3, indicating a platform or template version change rather than a modification to the study record.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.